Cargando…

Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities

BACKGROUND: From the morphological appearance, it was impossible to distinguish terminal portal venules from small lymphatic vessels in the portal tract even using histochemical microscopic techniques. Recently, D2-40 was found to be expressed at a high level in lymphatic endothelial cells (LECs). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokomori, Hiroaki, Oda, Masaya, Kaneko, Fumihiko, Kawachi, Shigeyuki, Tanabe, Minoru, Yoshimura, Kazunori, Kitagawa, Yuko, Hibi, Toshifumi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995474/
https://www.ncbi.nlm.nih.gov/pubmed/21059220
http://dx.doi.org/10.1186/1471-230X-10-131
_version_ 1782193084146122752
author Yokomori, Hiroaki
Oda, Masaya
Kaneko, Fumihiko
Kawachi, Shigeyuki
Tanabe, Minoru
Yoshimura, Kazunori
Kitagawa, Yuko
Hibi, Toshifumi
author_facet Yokomori, Hiroaki
Oda, Masaya
Kaneko, Fumihiko
Kawachi, Shigeyuki
Tanabe, Minoru
Yoshimura, Kazunori
Kitagawa, Yuko
Hibi, Toshifumi
author_sort Yokomori, Hiroaki
collection PubMed
description BACKGROUND: From the morphological appearance, it was impossible to distinguish terminal portal venules from small lymphatic vessels in the portal tract even using histochemical microscopic techniques. Recently, D2-40 was found to be expressed at a high level in lymphatic endothelial cells (LECs). This study was undertaken to elucidate hepatic lymphatic vessels during progression of cirrhosis by examining the expression of D2-40 in LECs. METHODS: Surgical wedge biopsy specimens were obtained from non-cirrhotic portions of human livers (normal control) and from cirrhotic livers (LC) (Child A-LC and Child C-LC). Immunohistochemical (IHC), Western blot, and immunoelectron microscopic studies were conducted using D2-40 as markers for lymphatic vessels, as well as CD34 for capillary blood vessels. RESULTS: Imunostaining of D2-40 produced a strong reaction in lymphatic vessels only, especially in Child C-LC. It was possible to distinguish the portal venules from the small lymphatic vessels using D-40. Immunoelectron microscopy revealed strong D2-40 expression along the luminal and abluminal portions of the cell membrane of LECs in Child C-LC tissue. CONCLUSION: It is possible to distinguish portal venules from small lymphatic vessels using D2-40 as marker. D2-40- labeling in lymphatic capillary endothelial cells is related to the degree of fibrosis in cirrhotic liver.
format Text
id pubmed-2995474
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29954742010-12-02 Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities Yokomori, Hiroaki Oda, Masaya Kaneko, Fumihiko Kawachi, Shigeyuki Tanabe, Minoru Yoshimura, Kazunori Kitagawa, Yuko Hibi, Toshifumi BMC Gastroenterol Research Article BACKGROUND: From the morphological appearance, it was impossible to distinguish terminal portal venules from small lymphatic vessels in the portal tract even using histochemical microscopic techniques. Recently, D2-40 was found to be expressed at a high level in lymphatic endothelial cells (LECs). This study was undertaken to elucidate hepatic lymphatic vessels during progression of cirrhosis by examining the expression of D2-40 in LECs. METHODS: Surgical wedge biopsy specimens were obtained from non-cirrhotic portions of human livers (normal control) and from cirrhotic livers (LC) (Child A-LC and Child C-LC). Immunohistochemical (IHC), Western blot, and immunoelectron microscopic studies were conducted using D2-40 as markers for lymphatic vessels, as well as CD34 for capillary blood vessels. RESULTS: Imunostaining of D2-40 produced a strong reaction in lymphatic vessels only, especially in Child C-LC. It was possible to distinguish the portal venules from the small lymphatic vessels using D-40. Immunoelectron microscopy revealed strong D2-40 expression along the luminal and abluminal portions of the cell membrane of LECs in Child C-LC tissue. CONCLUSION: It is possible to distinguish portal venules from small lymphatic vessels using D2-40 as marker. D2-40- labeling in lymphatic capillary endothelial cells is related to the degree of fibrosis in cirrhotic liver. BioMed Central 2010-11-08 /pmc/articles/PMC2995474/ /pubmed/21059220 http://dx.doi.org/10.1186/1471-230X-10-131 Text en Copyright ©2010 Yokomori et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yokomori, Hiroaki
Oda, Masaya
Kaneko, Fumihiko
Kawachi, Shigeyuki
Tanabe, Minoru
Yoshimura, Kazunori
Kitagawa, Yuko
Hibi, Toshifumi
Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title_full Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title_fullStr Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title_full_unstemmed Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title_short Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
title_sort lymphatic marker podoplanin/d2-40 in human advanced cirrhotic liver- re-evaluations of microlymphatic abnormalities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995474/
https://www.ncbi.nlm.nih.gov/pubmed/21059220
http://dx.doi.org/10.1186/1471-230X-10-131
work_keys_str_mv AT yokomorihiroaki lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT odamasaya lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT kanekofumihiko lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT kawachishigeyuki lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT tanabeminoru lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT yoshimurakazunori lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT kitagawayuko lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities
AT hibitoshifumi lymphaticmarkerpodoplanind240inhumanadvancedcirrhoticliverreevaluationsofmicrolymphaticabnormalities